መነሻ › አልዛይመር በሽታ › ሚሺጋን
በሚሺጋን ለአልዛይመር በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአልዛይመር በሽታ የሚደረጉ 15 ጥናቶች በሚሺጋን ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በሚሺጋን ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ60 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
ተሳታዮችን በመፈለግ ላይ
እድሜ 70 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ጁላይ 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ45 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ60 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT06584357ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።